Oculus Innovative Sciences, Inc. (OCLS) launched two new Microcyn-based advanced wound care products in the U.S. Oculus’ shares gained around 8.7% on the news to end the trading session on Jan 7 at $3.89.
The first of the two products is the spray formulation of the three-ounce Microcyn skin & wound spray hydroGel which can easily be sprayed directly into the wound. The product uses Oculus’ hypochlorous acid hydrogel technology.
The other product is a proven and easy-to-use Microcyn wound & skin care with preservatives available in a two-ounce bottle for both clinical and economical in-home patient usage. Microcyn helps to cleanse, irrigate and aid in the debridement of a wide array of chronic and acute wounds.
The product can be used prior to a variety of wound healing products. Oculus believes that the smaller version of the product can also be economically dispensed or prescribed for in-home use apart from clinical usage.
We note that the company has progressed well with its Microcyn family of products. Last month, the U.S. Food and Drug Administration (FDA) cleared Microcyn Scar Management HydroGel. The product was approved for the management of old and new hypertrophic and keloid scarring resulting from burns, general surgical procedures and trauma wounds. The product was approved for the indication under a healthcare professional’s supervision.
Oculus expects its U.S. partner, Quinnova Pharmaceuticals, to launch Microcyn Scar Management hydroGel in the second quarter of 2014. Oculus is also working with other partners to make the product available worldwide.
We are encouraged by the company’s new launches and expect investor focus to remain on its Microcyn- based products going forward.
Oculus presently carries a Zacks Rank #4 (Sell). Some better-ranked stocks include Forest Laboratories Inc. (FRX), WuXi PharmaTech (Cayman) Inc. (WX) and Gentium (GENT). All these stocks carry a Zacks Rank #1 (Strong Buy).
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment